Explore evidence

11 %All-cause mortality during TB treatment was 11% among men and 9% among women among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

28.6 %Among 213 children, 28.6% had CFP-10/ESAT-6-specific CD4 and/or CD8 responses through 24 months.

Kenyatuberculosepublished 2026The Journal of infectious diseasesPubMeddocument of 4 observations

8.2 per_1000_person_yearsThe tuberculosis incidence rate among children living with HIV aged <15 years who initiated but did not complete isoniazid preventive therapy was 8.2 per 1000 person years by 24 months after IPT screening.

Kenyatuberculoseobserved by 24 months after IPT screeningpublished 2022Journal of the International AIDS SocietyPubMeddocument of 7 observations

11.4 %Penicillium spp. were isolated from 10 out of 88 fungal-positive sputum samples (11.4%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

2,084 deathsAmong TB patients, 2084 (7.6%) died during treatment.

Kenyatuberculoseobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

AFRICOS participants had significantly higher rates of tuberculosis compared to DC Cohort participants.

Kenyatuberculosepublished 2022PloS onePubMeddocument of 13 observations

0.25 kendall_tauMtb antigen-specific IL2/IP10 responses had fair correlation (τ = 0.25).

Kenyatuberculosepublished 2021The Pediatric infectious disease journalPubMeddocument of 3 observations

11,633 patients11,633 (90%) of the included TB patients were given first-line TB treatment.

Kenyatuberculoseobserved 2012 to 2018published 2021Scientific reportsPubMeddocument of 12 observations

36 %Among 70 participants who completed two months of intensive phase TB chemotherapy, 25 (36%) were sputum positive at the end of two months.

Kenyatuberculosepublished 2014HealthOpenAlexdocument of 4 observationsDOI 10.4236/health.2014.615237

12,856 patientsA total of 12,856 TB patients were included in the study.

Kenyatuberculoseobserved 2012 to 2018published 2021Scientific reportsPubMeddocument of 12 observations

7.6 %Mtb infection prevalence at 12-month follow-up was 7.6% in the INH arm among 132 infants.

Kenyatuberculosepublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 10 observations

6.2 %A small proportion (6.2%) of specimens with ZN and culture negative results was positive by GeneXpert.

Kenyatuberculoseobserved 2013-2014published 2019African Journal of Health SciencesOpenAlexdocument of 6 observations

71.4 %GeneXpert detected Mycobacterium tuberculosis with a sensitivity of 71.4% (95% CI: 52.1–90.7%) in salivary sputum specimens from HIV-negative individuals.

Kenyatuberculosepublished 2014African Journal of Health SciencesOpenAlexdocument of 13 observations

38 %Mycological investigation of sputum samples from PTB patients in Kenya yielded positive fungal culture in 88 out of 234 samples, representing 38%.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

There was no Mycobacterium tuberculosis polyresistant strain identified in Migori and Siaya counties among HIV-negative tuberculosis patients in Western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

248 casesOut of 426 tuberculosis suspects, 248 (58.2%) had delayed in seeking medical care.

Kenyatuberculosepublished 2012DOAJ (DOAJ: Directory of Open Access Journals)OpenAlexdocument of 2 observations

-0.15 z-scoreThe tuberculosis–antiretroviral therapy group had height-for-age z-score of -0.15 (95% CI: -0.29 to -0.01) over 6-month follow-up.

Kenyatuberculose · VIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations

83 %HIV testing uptake among TB patients in Kenya increased from 83% in 2008 to 98% in 2018.

Kenyatuberculose · VIH/sidaobserved 2008published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

82,313 casesIn 2015, 82,313 TB cases were notified in Kenya.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

28 %Aspergillus spp. were isolated from 25 out of 88 fungal-positive sputum samples (28%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

76.7 %GeneXpert detected Mycobacterium tuberculosis with a sensitivity of 76.7% (95% CI: 64.1–89.3%) in salivary sputum specimens.

Kenyatuberculosepublished 2014African Journal of Health SciencesOpenAlexdocument of 13 observations

9 %Of 11,376 adults with presumptive TB identified in 143 health facilities, 1038 (9%) tested HIV positive.

Kenyatuberculose · VIH/sidaobserved 2018published 2022International journal of STD & AIDSPubMeddocument of 4 observations

84.4 %GeneXpert sensitivity in HIV positive people with presumptive TB was 84.4%, compared to 53.1% for ZN microscopy and 56.3% for LED fluorescent microscopy.

Kenyatuberculoseobserved 2013-2014published 2019African Journal of Health SciencesOpenAlexdocument of 6 observations

72 %Majority (72%) of HIV-negative tuberculosis patients died from tuberculosis-related lung disease.

Kenyatuberculose · VIH/sidapublished 2023African health sciencesPubMeddocument of 6 observations

There was no second-line drug monoresistance among HIV-positive tuberculosis patients in Western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations